SCHEMBL30769423

SCHEMBL30769423

CON(C)C(=O)COCc1cc(OCc2ccccc2)ccc1Br

nearest known ligand 0.47

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 2/20 0.47
▸ NPC1 O15118 1/20 0.47
▸ LTB4R Q15722 4/20 0.46
▸ LTB4R2 Q9NPC1 4/20 0.46
▸ ALOX5 P09917 2/20 0.45
▸ ALDH1A1 P00352 1/20 0.44
▸ SMN1; SMN2 Q16637 1/20 0.44
▸ BACE1 P56817 1/20 0.43
▸ MAOB P27338 3/20 0.43
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ MEN1 O00255 2/20 0.41
▸ KMT2A Q03164 2/20 0.41
▸ CYP2D6 P10635 1/20 0.41
▸ POLB P06746 1/20 0.41
▸ SRD5A2 P31213 1/20 0.41
▸ PKM P14618 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30768454 0.83 FFAR1 (0.47) RAB9AALOX5ALDH1A1SMN1; SMN2BACE1
SCHEMBL30769458 0.80 NPC1 (0.44) RAB9ANPC1LTB4RLTB4R2ALOX5
SCHEMBL4234185 0.79 NPC1 (0.47) RAB9ANPC1ALOX5ALDH1A1SMN1; SMN2
SCHEMBL30768565 0.79 MAOB (0.43) RAB9ANPC1LTB4RLTB4R2ALDH1A1
SCHEMBL30768416 0.78 MAOB (0.41) RAB9ANPC1LTB4RLTB4R2ALOX5
SCHEMBL28866139 0.78 MAOB (0.54) RAB9AALOX5SMN1; SMN2MAOBL3MBTL1
SCHEMBL2434378 0.75 MAOB (0.51) RAB9ANPC1LTB4RLTB4R2ALOX5
SCHEMBL2133357 0.75 MAOB (0.54) ALOX5MAOBL3MBTL1
SCHEMBL29925382 0.75 MAOB (0.54) ALOX5MAOBL3MBTL1
SCHEMBL2353230 0.73 ALOX5 (0.76) RAB9ANPC1LTB4RLTB4R2ALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4543871-A1 ESTROGEN RECEPTOR ALPHA DEGRADERS AND USE THEREOF Relay Therapeutics, Inc. (US) 2025-04-30 — — EP disclosed
WO-2024006781-A1 ESTROGEN RECEPTOR ALPHA DEGRADERS AND USE THEREOF RELAY THERAPEUTICS, INC. (US) 2024-01-04 — — WO disclosed
Send feedback